This webinar will be a panel discussion of the topic.
IBC oversight of studies involving transfer of recombinant DNA/RNA or recombinant micro-organisms to human research study subjects can be complex. We will review the NIH guidelines that apply to human research and benchmark how different institutions handle IBC approvals. There will be a panel discussion on institutional experiences of hearing gene therapy studies using an internal IBC vs. using a third-party (external) IBC.
This webinar is our inaugural webinar on our new ZOOM platform.
After registering, you will receive a confirmation email containing information about joining the webinar.